ClinicalTrials.govpublic full text
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
asthma, moderate to severe asthma, rocatinlimab, amg 451, khk4083, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 832662
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.